MARTINGALE ASSET MANAGEMENT L P

Position in PCVX — Vaxcyte, Inc.

CIK 936944 BOSTON, MA

Position in PCVX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,182,490

+$788,315 QoQ

Shares Held

37,545

+56.5% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#133

of 329 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 35% Shared 0% None 65%

Healthcare · as of Jun 30, 2026

MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. PCVX ranks #18 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	42,729	$21,224,776
2	INCY	Incyte Corp	168,818	$19,137,208
3	JAZZ	Jazz Pharmaceuticals plc	59,492	$14,335,787
4	REGN	Regeneron Pharmaceuticals, Inc.	18,953	$11,817,953
5	LGND	Ligand Pharmaceuticals Inc	17,562	$5,551,172
6	ACAD	Acadia Pharmaceuticals Inc	167,893	$4,247,692
7	ALNY	Alnylam Pharmaceuticals, Inc.	13,634	$4,104,243
8	INVA	Innoviva, Inc.	165,115	$3,749,761

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,182,490	37,545	+56.5%	Shares	Sole	2026-08-13
2026-03-31	$1,394,175	23,992	0.0%	Shares	Sole	2026-05-13
2025-12-31	$1,106,990	23,992	+1.7%	Shares	Sole	2026-02-13
2025-09-30	$849,747	23,591	+94.3%	Shares	Sole	2025-11-13
2025-06-30	$394,638	12,139	-22.2%	Shares	Sole	2025-08-11
2024-09-30	$1,783,183	15,605	-9.6%	Shares	Sole	2024-11-14
2024-06-30	$1,303,981	17,269	+9.0%	Shares	Sole	2024-08-12
2024-03-31	$1,082,030	15,840	-0.0%	Shares	Sole	2024-05-14
2023-12-31	$994,940	15,843	-52.7%	Shares	Sole	2024-02-12
2022-09-30	$804,312	33,513	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.